The Current Ratio as of December 2024 (TTM) for Smith & Nephew plc (SNNUF) is 2.51

According to Smith & Nephew plc’s latest financial reports and current stock price. The company's current Current Ratio is 2.51. This represents a change of 17.14% compared to the average of 2.14 of the last 4 quarters.

Smith & Nephew plc (SNNUF) Historical Current Ratio (quarterly & annually)

How has SNNUF Current Ratio performed in the past?

The mean historical Current Ratio of Smith & Nephew plc over the last ten years is 2.09. The current 2.51 Current Ratio has changed 11.92% with respect to the historical average. Over the past ten years (40 quarters), SNNUF's Current Ratio was at its highest in in the September 2020 quarter at 2.76. The Current Ratio was at its lowest in in the September 2023 quarter at 1.77.

Smith & Nephew plc (SNNUF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Smith & Nephew plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Smith & Nephew plc (SNNUF) Average Current Ratio

How has SNNUF Current Ratio performed in the past?

The current Current Ratio of Smith & Nephew plc (SNNUF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Smith & Nephew plc (SNNUF) Current Ratio vs. Peers

How is SNNUF’s Current Ratio compared to its peers?

Smith & Nephew plc’s Current Ratio is greater than Sonova Holding AG (1.45), greater than Medtronic plc (1.84), greater than CONMED Corporation (2.27), greater than NuVasive, Inc. (1.21), less than Glaukos Corporation (5.54), less than Integer Holdings Corporation (3.28), less than OrthoPediatrics Corp. (7.17), less than LivaNova PLC (3.37), less than Paragon 28, Inc. (3.50), less than Talis Biomedical Corporation (7.76), less than AxoGen, Inc. (3.74), less than Apyx Medical Corporation (5.46), less than Tivic Health Systems, Inc. (5.65), greater than Lucid Diagnostics Inc. (1.18),

Build a custom stock screener for Smith & Nephew plc (SNNUF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Smith & Nephew plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Smith & Nephew plc (SNNUF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Smith & Nephew plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.